Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | BCL2 | P10415 | 2/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.40 |
| ▸ | COMT | P21964 | 1/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3525616 | 0.86 | KMT2A (0.43) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3515715 | 0.84 | KMT2A (0.42) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3518219 | 0.84 | DPP4 (0.44) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3517548 | 0.84 | KMT2A (0.44) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3518351 | 0.84 | KDM4E (0.47) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3518784 | 0.84 | KMT2A (0.42) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3516992 | 0.83 | COMT (0.43) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3519938 | 0.81 | IP6K1 (0.41) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3519936 | 0.81 | IP6K1 (0.41) | KDM4ERCE1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL3517390 | 0.81 | KDM4E (0.41) | KDM4ERCE1KMT2ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056516-A1 | 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS | MERCK SHARP & DOHME CORP. | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056516-A1 | 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS | RNASEH1, RNASE1, RNASEL | KDM4E 2380/4885RCE1 283/4885KMT2A 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.